NeuroDerm Announces

... Read more

NeuroDerm to Replace Two Phase 3 Clinical Trials with Small Pharmacokinetic

... Read more

NeuroDerm Achieves Primary Endpoint in ND0612H Phase II Trial for Advanced

... Read more

NeuroMetrix Reports Japan Regulatory Approval for NC-stat DPNCheck

... Read more

NeuroMetrix Announces Availability of Quell in Approximately 1,000 Chain Drug

... Read more

NeuroMetrix Announces Issuance of New U.S. Patent for Quell Wearable Pain

... Read more

Nevada Sunrise drill program mobilization underway at

... Read more

Nevada Sunrise Acquires Neptune Lithium Property In Nevada

... Read more

Nevada Sunrise Receives Drill Permits for Clayton NE and Gemini Lithium

... Read more

New Gold Announces Sale

... Read more